Why the study?
Does D-dimer level predict disease severity in hospitalized adult patients with COVID-19 pneumonia?
Does D-dimer level predict disease severity in hospitalized adult patients with COVID-19 pneumonia?
D-dimer levels show significant differences across varying clinical severities of COVID-19 pneumonia, suggesting its utility as a biomarker for disease severity.
May inform severity stratification in COVID-19 pneumonia; hypothesis-generating, requires prospective validation before clinical use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Devi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: